This year saw notable progress in head and neck cancers, Huntington's disease, personalized genetic therapy, and heart ...

All-RNA, non-viral, LNP-based PRINT™ platform is designed to develop safer, durable, one-time therapies for a broad range of unmet needsAddition is advancing a robust pipeline of PRINTed therapeutics ...

The critical work of those racing to cure rare pediatric diseases got an important shot in the arm today. Florida’s newly created Sunshine Genetics Consortium promises hope for children living with ...

Exsilio Therapeutics launched on Wednesday with an $82 million series A fundraising round co-led by Novartis Venture Fund and Delos Capital. The company’s interim CEO, Tal Zaks, says that while ...

To our immune system, a potentially lifesaving gene therapy can look a lot like a dangerous infection. That's because most ...

Artificial Intelligence (AI) is transforming the landscape of genomic medicine, unlocking opportunities to accelerate the discovery of relevant alterations, improve and democratise molecular ...

The sequencing of the human genome has created an unprecedented opportunity to apply new knowledge and technology to improve human health. The goal of the CCTS Genomic & Precision Medicine Special ...

Dr. David Buchner is an accomplished geneticist and educator whose career spans more than two decades of research and leadership in human genetics, metabolic disease, and computational genomics. He ...

A research team led by the Department of Pediatrics and Adolescent Medicine, School of Clinical Medicine, LKS Faculty of ...

The Department of Genetics and Genome Sciences is proud to offer a Master’s degree in Computational Genomic Medicine for motivated students who wish to prepare for conducting genomics research and/or ...